Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/1995
11/28/1995US5470846 Treatment of neurological and mental disorders
11/28/1995US5470844 Heterocyclic-NMDA antagonists
11/28/1995US5470843 Carbohydrate-containing polymers, their preparation and use
11/28/1995US5470842 Carbohydrate-based anti-inflammatory agents
11/28/1995US5470841 Metabolizable plasma substitute
11/28/1995US5470840 Anti-inflammatory compounds and compositions
11/28/1995US5470839 Enteral diet and method for providing nutrition to a diabetic
11/28/1995US5470838 Method of delivering exogenous uridine or cytidine using acylated uridine or cytidine
11/28/1995US5470837 Autoimmune disease
11/28/1995US5470832 Inhibitors of geranylgeranyl-protein transferase
11/28/1995US5470589 Hardening agent for affected tissues of the digestive system
11/28/1995US5470587 Composition and method for treatment of patulous eustachian tube syndrome and atrophic rhinitis
11/28/1995US5470584 Diltiazem formulation
11/28/1995US5470580 Analgesics in tablet form
11/28/1995US5470579 Xanthines, optionally incorporated in liposomes, for promoting skin or hair pigmentation
11/28/1995US5470578 Antirheumatic composition
11/28/1995US5470574 Active principle isolated from shark tissue
11/28/1995US5470568 Nonionic polymer of ethylene oxide and propylene oxide for reduction of radiation damage
11/28/1995US5470566 Chewing gum, urea plaque acid neutralizer
11/28/1995US5470565 Toothpaste, tooth powder, mouthwash
11/28/1995US5470309 Medical ablation apparatus utilizing a heated stylet
11/28/1995CA2150204A1 Composition consisting of a dendrimer and an active substance occluded in the dendrimer, a process for the preparation of such a composition and a process for releasing the activesubstance
11/28/1995CA2150093A1 1,9-bridged thiazolo[3,2-a]quinoline derivatives
11/28/1995CA2091986C Certain cycloalkyl and azacycloalkyl pyrrolopyrimidines; a new class of gaba brain receptor ligands
11/28/1995CA2023018C 2-oxo-3,8-diazaspiro /4,5/decane derivatives, pharmaceutical compositions containing them and process for preparing the same
11/28/1995CA2006821C Substance dc 113 and production thereof
11/28/1995CA1337670C Cell growth inhibitory substance
11/28/1995CA1337660C Alkoxy-substituted dihydrobenzopyran-2-carboxylate derivatives
11/28/1995CA1337659C Optical isomers of an imidazole derivative
11/28/1995CA1337655C 1,2,3,4-tetrahydro-6-substituted-4-aryl(or heterocyclo)-3-¬(substituted amino)carbonyl|-2-thioxo(or oxo)-5-pyrimidinecarboxylic acids and esters
11/28/1995CA1337654C Fused tricyclic lactams as antihypertensive agents
11/28/1995CA1337653C 2-hydroxy-3-phenoxypropyl-substituted piperazines and homopiperazines, the preparation and use thereof
11/28/1995CA1337651C Pheophorbide derivatives
11/28/1995CA1337645C Teicoplanin-like derivatives
11/28/1995CA1337643C Method and microorganism for the production of faeriefungin
11/27/1995CA2124396A1 Chemical compounds
11/25/1995CA2124169A1 Chemical compounds
11/23/1995WO1995031566A1 Compositions and methods for targeting gene delivery vehicles
11/23/1995WO1995031560A1 Dna construct for effecting homologous recombination and uses thereof
11/23/1995WO1995031545A2 Diagnostics and treatments for cancers expressing tyrosine phosphorylated crkl protein
11/23/1995WO1995031544A1 Modulator of tnf/ngf superfamily receptors and soluble oligomeric tnf/ngf superfamily receptors
11/23/1995WO1995031541A2 Methods and compositions for treatment of restenosis and cancer using ribozymes
11/23/1995WO1995031538A1 Human dna topoisomerase i-alpha
11/23/1995WO1995031464A1 New agonist compounds
11/23/1995WO1995031463A1 New antagonist compounds
11/23/1995WO1995031457A1 Derivatives of quinuclidine n-oxide as muscarinic receptor ligands
11/23/1995WO1995031455A1 Quinolinecarboxylic acid derivative
11/23/1995WO1995031454A1 New azolidinediones as antihyperglycemic agents
11/23/1995WO1995031451A1 Novel compounds
11/23/1995WO1995031443A1 Acid amide derivatives and process for the preparation thereof
11/23/1995WO1995031437A1 Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudormophs thereof
11/23/1995WO1995031434A1 Complementary dna and toxins
11/23/1995WO1995031218A1 Selenium conjugates for the preparation of free radical pharmaceuticals
11/23/1995WO1995031207A1 Antithrombin agents in treatment of asthma
11/23/1995WO1995031206A1 P75 tnf receptor promoters
11/23/1995WO1995031205A1 Sialic acid/fucose based medicaments
11/23/1995WO1995031203A1 Oral liquid alendronate formulations
11/23/1995WO1995031202A1 Cage compounds, processes for their preparation and their use as antiviral agents
11/23/1995WO1995031201A1 Topical preparation containing aciclovir
11/23/1995WO1995031200A1 Pharmaceutical composition for treating glaucoma containing terazosin
11/23/1995WO1995031199A1 Use of clioquinol for treating helicobacter, including h. pylori, infections and related diseases
11/23/1995WO1995031198A1 Thiadiazoles and their use as antipicornaviral agents
11/23/1995WO1995031197A1 Methods of use for peroxynitrite decomposition catalysts, pharmaceutical compositions therefor
11/23/1995WO1995031196A1 Method of treatment for eiph in racing stock
11/23/1995WO1995031195A1 Use of no scavengers, inhibitors or antagonists in the treatment of migraine
11/23/1995WO1995031193A1 Matrix system for the transdermal delivery of ibuprofen, and method for preparing same
11/23/1995WO1995031192A1 Method and use of agents to inhibit protein polymerization and methods of identifying these agents
11/23/1995WO1995031191A1 Use of perfluorocarbons for assisting normal breathing in mammals having lung disorders
11/23/1995WO1995031182A1 Narcotic containing aerosol formulation
11/23/1995WO1995031180A1 A veterinary composition
11/23/1995WO1995031178A1 Mucoadhesive emulsions containing cyclodextrin
11/23/1995WO1995031104A1 Inhibition of insulin-induced adiposis
11/23/1995WO1995029257A3 Apolipoprotein e polymorphism and treatment of alzheimer's disease
11/23/1995WO1995028957A3 Methods for inducing t cell tolerance to a tissue or organ graft
11/23/1995WO1995024199A3 Use of compounds which inhibit phosphatidic acid formation for the manufacture of a medicament for the treatment of cancer
11/23/1995DE4417865A1 Two component tumour therapy using necrosis inducing agent
11/23/1995DE4417816A1 Agent to maintain and/or increases functionality of the skin
11/23/1995DE4417254A1 Lignin based products for use in veterinary medicine or animal hygiene
11/23/1995CA2578402A1 Human papilloma virus inhibition by a hairpin ribozyme
11/23/1995CA2190532A1 Acid amide derivatives and process for the preparation thereof
11/23/1995CA2190513A1 Methods and compositions for treatment of restenosis and cancer using ribozymes
11/23/1995CA2190475A1 Sialic acid/fucose based medicaments
11/23/1995CA2190289A1 Dna construct for effecting homologous recombination and uses thereof
11/23/1995CA2190161A1 Diagnostics and treatments for cancers expressing tyrosine phosphorylated crkl protein
11/23/1995CA2190145A1 Complementary dna and toxins
11/23/1995CA2190102A1 Human papilloma virus inhibition by a hairpin ribozyme
11/23/1995CA2190015A1 New azolidinediones as antihyperglycemic agents
11/23/1995CA2189983A1 Modulator of tnf/ngf superfamily receptors and soluble oligomeric tnf/ngf superfamily receptors
11/23/1995CA2189970A1 Matrix system for the transdermal delivery of ibuprofen, and method for preparing same
11/23/1995CA2189528A1 Methods of use for peroxynitrite decomposition catalysts, pharmaceutical compositions therefor
11/23/1995CA2189139A1 New agonist compounds
11/23/1995CA2187361A1 Pharmaceutical composition for treating glaucoma containing terazosin
11/23/1995CA2167055A1 Quinolinecarboxylic acid derivative
11/23/1995CA2158926A1 Compositions and methods for targeting gene delivery vehicles
11/22/1995EP0683172A1 11,21-Bisphenyl-19-norpregnane derivatives
11/22/1995EP0683170A1 Glucopyranoside benzothiophenes
11/22/1995EP0683169A1 8-Amino-pyrido 1,2,3-de 1,3,4 benzoxadiazine derivatives, and antibacterial agents containing them
11/22/1995EP0683168A1 Method for producing 2-methylspiro(1,3-oxathiolane-5,3')quinuclidine
11/22/1995EP0683167A1 Terazosin monohydrochloride and processes and intermediate for its production
11/22/1995EP0683166A1 3-Indolylpiperidines
1 ... 6965 6966 6967 6968 6969 6970 6971 6972 6973 6974 6975 6976 6977 6978 6979 6980 6981 6982 6983 6984 6985 ... 7860